Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients.

Synowiec, Agnieszka; Wcislo, Gabriel; Bodnar, Lubomir; Górski, Bohdan; Szenajch, Jolanta; Szarlej-Wcislo, Katarzyna; Szczylik, Cezary

Synowiec, Agnieszka; Wcislo, Gabriel; Bodnar, Lubomir; Górski, Bohdan; Szenajch, Jolanta; Szarlej-Wcislo, Katarzyna; Szczylik, Cezary.

Afiliación

Synowiec A; Department of Oncology, Military Institute of Medicine, 128 Szaserow Str., 04-141 Warsaw, Poland.
Wcislo G; Department of Oncology, Military Institute of Medicine, 128 Szaserow Str., 04-141 Warsaw, Poland.
Bodnar L; Department of Oncology, Military Institute of Medicine, 128 Szaserow Str., 04-141 Warsaw, Poland.
Górski B; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Szenajch J; Department of Oncology, Military Institute of Medicine, 128 Szaserow Str., 04-141 Warsaw, Poland.
Szarlej-Wcislo K; Department of Oncology, Military Institute of Medicine, 128 Szaserow Str., 04-141 Warsaw, Poland.
Szczylik C; Department of Oncology, Military Institute of Medicine, 128 Szaserow Str., 04-141 Warsaw, Poland.

Hered Cancer Clin Pract ; 14: 1, 2016.

Article en En | MEDLINE | ID: mdl-26753012

Palabras clave

Chemotherapy; Germline mutations of BRCA1; Ovarian cancer; Survival

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Hered Cancer Clin Pract Año: 2016 Tipo del documento: Article País de afiliación: Polonia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google